Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionEverence Capital Management Inc
Latest Disclosed Ownership4,274 shares
Latest Disclosed Value $ 1,909
Everence Capital Management Inc ownership in VRTX / Vertex Pharmaceuticals Incorporated

On April 28, 2026 - Everence Capital Management Inc filed a 13F-HR form disclosing ownership of 4,274 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $1,908,512 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 4,274 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 0.00% during the quarter. The current value of the position is $1,887,997 USD.

Everence Capital Management Inc has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F VERTEX PHARM EQTY 92532F100 4,274 0 0.00 2 0.00 0.1164
2026-02-03 2025-12-31 13F VERTEX PHARM EQTY 92532F100 4,274 0 0.00 2 0.00 0.1147
2025-10-01 2025-09-30 13F VERTEX PHARM EQTY 92532F100 4,274 -790 -15.60 2 -50.00 0.1003
2025-07-29 2025-06-30 13F VERTEX PHARM EQTY 92532F100 5,064 0 0.00 2 0.00 0.1451
2025-04-22 2025-03-31 13F VERTEX PHARM EQTY 92532F100 5,064 0 0.00 2 0.00 0.1670
2025-01-03 2024-12-31 13F VERTEX PHARM EQTY 92532F100 5,064 -280 -5.24 2 0.00 0.1325
2024-10-21 2024-09-30 13F VERTEX PHARM EQTY 92532F100 5,344 0 0.00 2 0.00 0.1568
2024-07-03 2024-06-30 13F VERTEX PHARMACEUTICALS EQTY 92532F100 5,344 0 0.00 2 0.00 0.1455
2024-05-08 2024-03-31 13F VERTEX PHARMACEUTICALS EQTY 92532F100 5,344 0 0.00 2 0.00 0.1476
2024-01-30 2023-12-31 13F VERTEX PHARMACEUTICALS EQTY 92532F100 5,344 -2,980 -35.80 2 0.00 0.1551
2023-10-16 2023-09-30 13F VERTEX PHARMACEUTICALS EQTY 92532F100 8,324 0 0.00 3 0.00 0.2249
2023-07-14 2023-06-30 13F VERTEX PHARMACEUTICALS EQTY 92532F100 8,324 0 0.00 3 0.00 0.2188
2023-04-04 2023-03-31 13F VERTEX PHARMACEUTICALS EQTY 92532F100 8,324 -2,490 -23.03 3 -33.33 0.2145
2023-01-31 2022-12-31 13F VERTEX PHARMACEUTICALS EQTY 92532F100 10,814 4,030 59.40 3 -99.85 0.2692
2022-10-07 2022-09-30 13F VERTEX PHARMACEUTICALS EQTY 92532F100 6,784 0 0.00 1,964 2.72 0.1815
2022-07-26 2022-06-30 13F VERTEX PHARMACEUTICALS EQTY 92532F100 6,784 1,080 18.93 1,912 28.41 0.1705
2022-04-11 2022-03-31 13F VERTEX PHARMACEUTICALS EQTY 92532F100 5,704 -1,570 -21.58 1,489 -6.76 0.1140
2022-01-28 2021-12-31 13F VERTEX PHARMACEUTICALS EQTY 92532F100 7,274 0 0.00 1,597 21.08 0.1186
2021-10-21 2021-09-30 13F VERTEX PHARMACEUTICALS EQTY 92532F100 7,274 1,570 27.52 1,319 14.70 0.1083
2021-07-12 2021-06-30 13F VERTEX PHARMACEUTICALS EQTY 92532F100 5,704 0 0.00 1,150 -6.20 0.0946
2021-04-06 2021-03-31 13F VERTEX PHARMACEUTICALS EQTY 92532F100 5,704 0 0.00 1,226 -9.05 0.1116
2021-02-01 2020-12-31 13F/A-1 VERTEX PHARMACEUTICALS EQTY 92532F100 5,704 0 0.00 1,348 -13.14 0.1314
2021-02-01 2020-09-30 13F/A-1 VERTEX PHARMACEUTICALS EQTY 92532F100 5,704 -180 -3.06 1,552 -8.38 0.1707
2020-07-09 2020-06-30 13F/A-1 VERTEX PHARMACEUTICALS EQTY 92532F100 5,884 0 0.00 1,694 21.00 0.1995
2020-07-07 2020-06-30 13F VERTEX PHARMACEUTICALS ORD EQTY 92532F100 5,884 1,673
2020-07-09 2020-03-31 13F/A-2 VERTEX PHARMACEUTICALS EQTY 92532F100 5,884 0 0.00 1,400 8.70 0.1970
2020-04-27 2020-03-31 13F/A-1 VERTEX PHARMACEUTICALS ORD EQTY 92532F100 5,884 0 1,400 0.2242
2020-04-23 2020-03-31 13F VERTEX PHARMACEUTICALS ORD EQTY 92532F100 5,884 0 1,288 192,196.9243
2020-01-28 2019-12-31 13F VERTEX PHARMACEUTICALS ORD EQTY 92532F100 5,884 0 0.00 1,288 29.19 0.1922
2019-10-09 2019-09-30 13F VERTEX PHARMACEUTICALS ORD EQTY 92532F100 5,884 0 0.00 997 -7.60 0.1615
2019-08-02 2019-06-30 13F VERTEX PHARMACEUTICALS ORD EQTY 92532F100 5,884 0 0.00 1,079 -0.28 0.1784
2019-05-06 2019-03-31 13F VERTEX PHARMACEUTICALS ORD EQTY 92532F100 5,884 0 0.00 1,082 10.97 0.1891
2019-02-05 2018-12-31 13F VERTEX PHARMACEUTICALS ORD EQTY 92532F100 5,884 0 0.00 975 -14.02 0.2260
2018-10-22 2018-09-30 13F VERTEX PHARMACEUTICALS ORD EQTY 92532F100 5,884 0 0.00 1,134 13.40 0.2252
2018-07-26 2018-06-30 13F VERTEX PHARMACEUTICALS ORD EQTY 92532F100 5,884 0 0.00 1,000 4.28 0.2114
2018-04-30 2018-03-31 13F VERTEX PHARMACEUTICALS ORD EQTY 92532F100 5,884 0 0.00 959 8.73 0.2122
2018-02-02 2017-12-31 13F VERTEX PHARMACEUTICALS ORD EQTY 92532F100 5,884 -1,128 -16.09 882 -17.26 0.1934
2017-10-31 2017-09-30 13F VERTEX PHARMACEUTICALS ORD EQTY 92532F100 7,012 0 0.00 1,066 17.92 0.2434
2017-08-04 2017-06-30 13F VERTEX PHARMACEUTICALS ORD EQTY 92532F100 7,012 0 0.00 904 17.86 0.2219
2017-04-19 2017-03-31 13F VERTEX PHARMACEUTICALS ORD EQTY 92532F100 7,012 0 0.00 767 48.36 0.2014
2017-02-07 2016-12-31 13F VERTEX PHARMACEUTICALS ORD EQTY 92532F100 7,012 0 0.00 517 -15.52 0.1486
2016-10-19 2016-09-30 13F Vertex Pharmaceuticals Common 92532F100 7,012 0 0.00 612 1.49 0.1816
2016-08-01 2016-06-30 13F Vertex Pharmaceuticals Common 92532F100 7,012 1,520 27.68 603 37.99 0.1850
2016-04-21 2016-03-31 13F Vertex Pharmaceuticals Common 92532F100 5,492 0 0.00 437 -36.76 0.1359
2016-02-02 2015-12-31 13F Vertex Pharmaceuticals Common 92532F100 5,492 1,410 34.54 691 62.59 0.2239
2015-11-03 2015-09-30 13F Vertex Pharmaceuticals Common 92532F100 4,082 0 0.00 425 -15.67 0.1466
2015-08-05 2015-06-30 13F Vertex Pharmaceuticals Common 92532F100 4,082 0 0.00 504 3.28 0.1630
2015-04-30 2015-03-31 13F Vertex Pharmaceuticals Common 92532F100 4,082 0 0.00 488 0.62 0.1636
2015-02-05 2014-12-31 13F Vertex Pharmaceuticals Common 92532F100 4,082 0 0.00 485 26.96 0.1661
2014-10-16 2014-09-30 13F Vertex Pharmaceuticals Common 92532F100 4,082 0 0.00 382 -1.04 0.1395
2014-08-04 2014-06-30 13F Vertex Pharmaceuticals Common 92532F100 4,082 0 0.00 386 33.56 0.1432
2014-04-16 2014-03-31 13F Vertex Pharmaceuticals Common 92532F100 4,082 0 0.00 289 -4.62 0.1140
2014-02-04 2013-12-31 13F Vertex Pharmaceuticals Common 92532F100 4,082 4,082 303 0.1221
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-04-06 2021-03-31 13F VERTEX PHARMACEUTICALS EQTY Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-01-11 2020-12-31 13F VERTEX PHARMACEUTICALS EQTY Put 5,704 0.00 1,348 -13.14 n/a n/a n/a
2020-10-20 2020-09-30 13F VERTEX PHARMACEUTICALS EQTY Put 5,704 1,552 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.